The General Director of Nobel Almaty Pharmaceutical Factory, Selcuk Tanriverdi, received remuneration of 93 million tenge for 2025. This amount includes salary and other payments, reports the website infohub.kz.
Compared to the previous year, the remuneration increased by 17%. On average, the executive's monthly income was 7.75 million tenge. Selcuk Tanriverdi, a Turkish citizen, has held the position of General Director since 2006 and also serves as Deputy Chairman of the Board of the parent company Nobel in Turkey.
The profit of the Kazakhstani enterprise increased by 11% over the year, reaching 27.8 billion tenge. Nobel AFF was founded in 2002 on the basis of the Almaty Pharmaceutical Factory. Currently, the company produces 104 molecules, presented on the market in the form of 228 medicinal products.
The enterprise is part of the Turkish holding Nobel Pharmaceuticals, founded in 1964. The holding manages five plants: three in Turkey, one in Kazakhstan, and one in Uzbekistan. The official founder of the Kazakhstani Nobel is Turkish citizen Ulusoy Hasan Ugur, who owns 90% of the voting shares.
Earlier it was reported that the Turkish company Nobel signed an investment agreement to build a new pharmaceutical plant in Kazakhstan worth 40 billion tenge.